Improve SCA Bridge Study

Improve Sudden Cardiac Arrest (SCA) Bridge Study

The purpose of the Improve SCA Bridge study is to characterize the care pathway flow of post-acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction (LVEF) in the acute phase (≤14 days post- acute MI) and chronic phase (≥40-90 days post-acute MI).

To determine how many patients are referred for sudden cardiac death (SCD) risk stratification and management, indicated for implantable cardioverter defibrillator (ICD), or cardiac resynchronization therapy- defibrillator (CRT-D) implant, and how many receive such devices within 12 months of experiencing an MI.

Inclusion Criteria:

• Age 18 and above (or meet age requirements per local law)
• Patients who have an acute Myocardial Infarction (MI) (STEMI or Non-STEMI) ≤ 30 days of study enrollment and have a LVEF <50% measurement ≤ 14 days post-acute MI
• Willing and able to give valid Informed Consent

Exclusion Criteria:

• Patient has previously received or currently implanted with an ICD or CRT-D
• Patient has any contraindication for ICD/CRT-D
• Patient has a life expectancy of less than 12 months
• Patient who has had an EP referral within the last 12 months
• Any exclusion criteria required by local law (e.g. pregnancy, breast feeding etc.)
• Patient is unable (e.g. mental disorder) or unwilling to be compliant with the responsibilities as specified in the informed consent form.
• Patient is enrolled in a concurrent study that has not been approved for concurrent enrollment by the Medtronic Clinical Trial Leader